Clinical efficacy of etanercept for treatment of PAPA syndrome.
| Publicado en: | JRC: Journal of Clinical Rheumatology Vol. 16; no. 5; pp. 244 - 246 |
|---|---|
| Autores principales: | , |
| Formato: | case study pictorial Journal Article |
| Publicado: |
Lippincott Williams & Wilkins
2010 Aug
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=105080029&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 105080029 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 10761608 N16 jtl: JRC: Journal of Clinical Rheumatology issn: 10761608 maglogo: N pubinfo: dt: 2010 Aug vid: 16 iid: 5 pid: 433 pub: Lippincott Williams & Wilkins place: Baltimore, Maryland artinfo: ui: 105080029 105080029 2010750490 10.1097/RHU.0b013e3181e969b9 NLM20661073 105080029 ppf: 244 ppct: 2 formats: tig: atl: Clinical efficacy of etanercept for treatment of PAPA syndrome. aug: au: Tofteland ND Shaver TS affil: Department of Internal Medicine, University of Kansas School of Medicine-Wichita, Wichita, KS 67214, USA. ntofteland@kumc.edu sug: subj: Etanercept Therapeutic Use Hereditary Diseases Pyoderma Gangrenosum Drug Therapy Skin Diseases, Genetic Wound Care Adrenal Cortex Hormones Therapeutic Use Debridement Etanercept Administration and Dosage Female Hereditary Diseases Physiopathology Middle Age Outpatients Pyoderma Gangrenosum Surgery Skin Diseases, Genetic Physiopathology Treatment Outcomes Wound Healing Middle Aged: 45-64 years Female pubtype: Academic Journal doctype: case study pictorial Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|